Literature DB >> 10817740

A new SHV-derived extended-spectrum beta-lactamase (SHV-24) that hydrolyzes ceftazidime through a single-amino-acid substitution (D179G) in the -loop.

H Kurokawa1, T Yagi, N Shibata, K Shibayama, K Kamachi, Y Arakawa.   

Abstract

A new SHV-derived extended-spectrum beta-lactamase (SHV-24) conferring high-level resistance to ceftazidime but not cefotaxime and cefazolin was identified in Japan. This enzyme was encoded by a transferable 150-kb plasmid from an Escherichia coli clinical isolate. The pI and K(m) for CAZ of this enzyme were 7.5 and 30 microM, respectively. SHV-24 was found to have a D179G substitution in the Omega-loop of the enzyme.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10817740      PMCID： PMC89944          DOI： 10.1128/AAC.44.6.1725-1727.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Structure of the SHV-1 beta-lactamase.

Authors:  A P Kuzin; M Nukaga; Y Nukaga; A M Hujer; R A Bonomo; J R Knox
Journal:  Biochemistry       Date:  1999-05-04       Impact factor: 3.162

2.  Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum beta-lactamase.

Authors:  G Arlet; M Rouveau; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1997-07-01       Impact factor: 2.742

3.  A standard numbering scheme for the class A beta-lactamases.

Authors:  R P Ambler; A F Coulson; J M Frère; J M Ghuysen; B Joris; M Forsman; R C Levesque; G Tiraby; S G Waley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

Review 4.  Is it important to identify extended-spectrum beta-lactamase-producing isolates?

Authors:  K Bush
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

5.  Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.

Authors:  J K Rasheed; C Jay; B Metchock; F Berkowitz; L Weigel; J Crellin; C Steward; B Hill; A A Medeiros; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  Nomenclature of TEM beta-lactamases.

Authors:  K Bush; G Jacoby
Journal:  J Antimicrob Chemother       Date:  1997-01       Impact factor: 5.790

7.  A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan.

Authors:  T Yagi; H Kurokawa; N Shibata; K Shibayama; Y Arakawa
Journal:  FEMS Microbiol Lett       Date:  2000-03-01       Impact factor: 2.742

8.  Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems.

Authors:  K Senda; Y Arakawa; K Nakashima; H Ito; S Ichiyama; K Shimokata; N Kato; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance.

Authors:  E Osano; Y Arakawa; R Wacharotayankun; M Ohta; T Horii; H Ito; F Yoshimura; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

10.  Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.

Authors:  Y Ishii; A Ohno; H Taguchi; S Imajo; M Ishiguro; H Matsuzawa
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191
View more
  14 in total

1.  Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.

Authors:  Aroonwadee Chanawong; Fatima Hannachi M'Zali; John Heritage; Jian-Hui Xiong; Peter Michael Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.

Authors:  Hiroshi Kurokawa; Naohiro Shibata; Yohei Doi; Keigo Shibayama; Kazunari Kamachi; Tetsuya Yagi; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

3.  A Genotype-Phenotype Correlation Study of SHV β-Lactamases Offers New Insight into SHV Resistance Profiles.

Authors:  Svetlana Neubauer; Sara Madzgalla; Mike Marquet; Anne Klabunde; Bernd Büttner; Alexander Göhring; Christian Brandt; Karl-Heinz Feller; Mathias W Pletz; Oliwia Makarewicz
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

4.  Practical methods using boronic acid compounds for identification of class C beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.

Authors:  Tetsuya Yagi; Jun-ichi Wachino; Hiroshi Kurokawa; Satowa Suzuki; Kunikazu Yamane; Yohei Doi; Naohiro Shibata; Haru Kato; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Ligand-dependent disorder of the Omega loop observed in extended-spectrum SHV-type beta-lactamase.

Authors:  Jared M Sampson; Wei Ke; Christopher R Bethel; S R R Pagadala; Michael D Nottingham; Robert A Bonomo; John D Buynak; Focco van den Akker
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

6.  SHV-16, a beta-lactamase with a pentapeptide duplication in the omega loop.

Authors:  C Arpin; R Labia; C Andre; C Frigo; Z El Harrif; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 7.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

8.  CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.

Authors:  L Poirel; T Naas; I Le Thomas; A Karim; E Bingen; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  An analysis of why highly similar enzymes evolve differently.

Authors:  Fahd K Majiduddin; Timothy Palzkill
Journal:  Genetics       Date:  2003-02       Impact factor: 4.562

10.  Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.

Authors:  Jun-ichi Wachino; Yohei Doi; Kunikazu Yamane; Naohiro Shibata; Tetsuya Yagi; Takako Kubota; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.